| Measuring the quality of life of severely mentally ill people using the Lancashire Quality of Life Profile | Social Psychiatry and Psychiatric Epidemiology | 1997 | 222 |
| Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium | Biological Psychiatry | 1997 | 127 |
| Association Analysis of a Regulatory Variation of the Serotonin Transporter Gene with Severe Alcohol Dependence | Alcoholism: Clinical and Experimental Research | 1997 | 127 |
| Dopamine D4 receptor exon III alleles and variation of novelty seeking in alcoholics | American Journal of Medical Genetics Part A | 1997 | 94 |
| Age-related cognitive decline and vision impairment affecting the detection of dementia syndrome in old age | British Journal of Psychiatry | 1997 | 82 |
| Lithium vs carbamazepine in the maintenance treatment of schizoaffective disorder: a randomised study | European Archives of Psychiatry and Clinical Neuroscience | 1997 | 60 |
| Melatonin effects in a patient with severe REM sleep behavior disorder: case report and theoretical considerations | Neuropsychobiology | 1997 | 53 |
| 1997 IPA/Bayer Research Awards in Psychogeriatrics. The wish to die in very old persons near the end of life: a psychiatric problem? Results from the Berlin Aging Study | International Psychogeriatrics | 1997 | 52 |
| Superiority of carbohydrate-deficient transferrin to gamma-glutamyltransferase in detecting relapse in alcoholism | American Journal of Psychiatry | 1997 | 51 |
| Randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a new isoindoline derivative (DN-2327) in generalized anxiety | | 1997 | 46 |
| Does quality of life differ in schizophrenic women and men? An empirical study | International Journal of Social Psychiatry | 1997 | 42 |
| A multicenter randomized double-blind study on the efficacy and safety of nicergoline in patients with multi-infarct dementia | Dementia and Geriatric Cognitive Disorders | 1997 | 38 |
| Moderate lesion of the rat cholinergic septohippocampal pathway increases hippocampal nerve growth factor synthesis: evidence for long-term compensatory changes? | Molecular Brain Research | 1997 | 30 |
| Serotonergic dysfunction in addiction: effects of alcohol, cigarette smoking and heroin on platelet 5-HT content | Psychiatry Research | 1997 | 29 |
| In an epidemiological sample the apolipoprotein E4 allele is associated to dementia and loss of memory function only in the very old | Neuroscience Letters | 1997 | 26 |
| Association analysis of a regulatory variation of the serotonin transporter gene with severe alcohol dependence | Alcoholism: Clinical and Experimental Research | 1997 | 24 |
| The impact of psychosocial and clinical variables on duration of inpatient treatment for depression | Social Psychiatry and Psychiatric Epidemiology | 1997 | 21 |
| The quality of life of patients with paranoid schizophrenia in London and Berlin | Social Psychiatry and Psychiatric Epidemiology | 1997 | 20 |
| Suicidality and tiredness of life among very old persons: Results from the Berlin aging study (base) | Archives of Suicide Research | 1997 | 19 |
| Long-term mental sequelae of torture in Iran--who seeks treatment? | Journal of Nervous and Mental Disease | 1997 | 19 |
| Guidelines for the implementation of drug utilization observation (DUO) studies in psychopharmacological therapy. The "Phase IV Research" Task-Force of the Association for Neuropsychopharmacology and Pharmacopsychiatry (AGNP) | Pharmacopsychiatry | 1997 | 12 |
| Neuropsychiatric aspects in Munchausen's syndrome | General Hospital Psychiatry | 1997 | 11 |
| 5-HT brain function in affective disorder: d,l-fenfluramine-induced hormone release and clinical outcome in long-term lithium/carbamazepine prophylaxis | Journal of Affective Disorders | 1997 | 9 |
| Initial response to active drug and placebo predicts outcome of antidepressant treatment | European Psychiatry | 1997 | 5 |
| What happens to patients after the end of a clinical trial? Systematic follow-up observational study of an open moclobemide trial in major depression | Pharmacopsychiatry | 1997 | 3 |
